ENTERAL FEEDING FORMULAS MARKET 規模とシェア分析 - 成長傾向と予測（2023年～2030年）

Enteral feeding formulas are nutritional supplements that are administered directly into the stomach, duodenum, or jejunum of individuals who cannot obtain adequate oral intake. There are different types of enteral feeding formulas available. Protein-based formulas contain protein as the main nutrient and are used for individuals who need nutrition support but minimal carbohydrate or fat intake. Standard formulas provide a balanced proportion of carbohydrates, proteins, and fats. They meet most daily nutritional needs and are suitable for long-term use. Disease-specific formulas are tailored for certain health conditions like diabetes, renal failure, or liver disease. Fiber-containing formulas provide soluble and insoluble fiber to promote normal bowel function.

Each type of formula has its own advantages and disadvantages. Protein-based formulas help meet protein needs without excess calories but lack balanced nutrition. Standard formulas provide balanced nutrition but may not meet special dietary needs. Disease-specific formulas address the unique nutritional requirements of certain illnesses but come at a higher cost. Fiber-containing formulas aid in regular bowel movements but have a thicker consistency and higher calorie content. The appropriate formula must be selected based on the individual's health status, nutritional requirements, and tolerateability. Enteral feeding ensures adequate nutrition in patients who cannot obtain nutrition through oral intake.

 Market Dynamics

The global enteral feeding formulas market is driven by the rising geriatric population, increasing incidence of chronic diseases, growing number of preterm births, and surging cases of dysphagia among adults. As per UN projections, the population aged 60 years and above will nearly double by 2050 and become larger than the youth population. The aged people is more prone to conditions requiring enteral feeding assistance like dementia and complications post-surgery. Additionally, chronic diseases like cancer, neurological disorders, and gastrointestinal illnesses, necessitating enteral nutrition aids are on the rise internationally. This is positively impacting the market growth. However, the availability of alternative delivery methods, risk of infections associated with tubes, and high costs of specialized formulas are restraining the market growth. The development of organic, non-GMO (non-genetically modified organisms), and allergen-free formulas presents lucrative opportunities for market players.

Key Features of the Study

• This report provides an in-depth analysis of the global enteral feeding formulas market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends,  regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global enteral feeding formulas market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Nestle, VICTUS, Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd., Mead Johnson & Company, LLC, Abbott, Danone S.A, and Fresenius Kabi AG.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global enteral feeding formulas market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enteral feeding formulas market.

Market Segmentation

• By Product
  • Standard Formula
  • Disease-specific Formulas
  • Elemental Formulas
  • Specialized Formulas
• By Flow Type
  • Intermittent Feeding Flow
  • Continuous Feeding Flow
• By Stage
  • Adults
  • Pediatrics
• By Indication
  • Alzheimer’s
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Others (Malabsorption/GI Disorder/Diarrhea, etc.)
• By End Use
  • Hospitals
    • Cardiology
    • Neurology
    • Critical Care (ICU)
    • Oncology
    • Others
  • Home Care
• By Sales Channel
  • Online Sales
  • Retail Sales
  • Institutional Sales
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Companies
  • Nestle
  • VICTUS
  • Primus Pharmaceuticals, Inc.
  • Meiji Holdings. Co., Ltd.
  • Mead Johnson & Company, LLC
  • Abbott
  • Danone S.A
  • Fresenius Kabi AG